Press Room

Press Room

Press release

Postmenopausal Canadian women experiencing vaginal dryness and painful intercourse have a new oral once-daily prescription treatment, Osphena® (ospemifene tablets) from Duchesnay

Read more >
Press release

Senior management team takes over ownership of Quebec-based multinational pharmaceutical group Duchesnay

Read more >
Press release

Duchesnay invests $3 million at its Blainville plant and increases its export capacity

Read more >
Press release

Population Council and Duchesnay Announce New International License Agreement for ANNOVERA®

Read more >
Press release

Duchesnay Inc. is seeking Health Canada's approval for ospemifene for the treatment of moderate to severe dyspareunia and vaginal dryness, symptoms of vulvar and vaginal atrophy (VVA), a component of genitourinary syndrome of menopause (GSM)

Read more >